Group Companies

NS Pharma,Inc

NS Pharma,Inc

Business lines

Clinical development and commercialization of pharmaceutical candidates created by Nippon Shinyaku, business development in collaboration with partners in North America, and information gathering to introduce promising pharmaceuticals developed by North American companies into Japan.

Representative director

Yukiteru Sugiyama, President

Head Office Address

140 East Ridgewood Avenue, Suite 280S Paramus, NJ 07652 U.S.A

Established

July 1, 1999

Capital

$ 300,000

Percentage of voting rights (%)

100

Employees

117 (as of March 31, 2024)

Website

https://www.nspharma.com/

北京艾努愛世医薬科技有限公司(Beijing Nippon Shinyaku Co., Ltd.)

北京艾努愛世医薬科技有限公司

Business lines

Support of development and sales of pharmaceuticals and functional foods, and collection of pharmaceutical information, etc.

Representative director

Zhang Xin, General Manager

Head Office Address

3002, Changfugong Office Building, No. 26, Jian Guo Men Wai street, Chaoyang District, Beijing, 100022, China

Established

September 1, 2021

Capital

2 million yuan

Percentage of voting rights (%)

100

天津艾努愛世医薬有限公司(Tianjin Nippon Shinyaku Co., Ltd.)

Business lines

Sales, import/export, and distribution of pharmaceuticals and functional foods, etc.

Representative director

Zhang Xin, General Manager

Head Office Address

1-1-2505, Shuangying building, intersection of heiniucheng road and Taihu Road, Hexi District, Tianjin

Established

November 9, 2021

Capital

79.55 million yuan

Percentage of voting rights (%)

100

Sioe Pharmaceutical Co., Ltd.

シオエ製薬株式会社

Business lines

Manufacture and sale of pharmaceuticals (ethical drugs, disinfectant, and pharmacopoeia-admitted drugs) and foodstuffs

Representative director

Noboru Nishikawa, President

Head Office Address

1-11, Shioe 3-chome, Amagasaki, Hyogo, Japan

Established

April 1946
(The Company's name changed in October 1976 from Kuroishi Pharmaceutical Co., Ltd. to Sioe Pharmaceutical Co., Ltd.)

Capital

30 million yen
(Nippon Shinyaku has made equity investment in the Company since July 1960 and currently wholly owns its shares.)

Percentage of voting rights (%)

100

Employees

40 (as of March 31, 2024)

Website

https://www.sioe-pharm.co.jp/

Tajima Shokuhin Kogyo Co., Ltd.

Tajima Shokuhin Kogyo

Business lines

Manufacture of foodstuffs (powdered protein ingredients, shelf life improvers, health food ingredients, etc.) and active pharmaceutical ingredients (APIs)

Representative director

Kouichi Tamura, President

Head Office Address

435, Higashishiba, Hidaka-cho, Toyooka, Hyogo, Japan

Established

June 1961
(The Company's name changed in December 1970 from Tajima Starch Manufacturing Co., Ltd. to Tajima Shokuhin Kogyo Co., Ltd.)

Capital

50 million yen
(Nippon Shinyaku has made equity investment in the Company since December 1970 and currently owns 84% of its shares.)

Percentage of voting rights (%)

83.5

Employees

78 (as of March 31, 2024)

Website

http://www.tajima-shokuhin.co.jp/

Nippon Shinyaku Advance Co., Ltd.

Nippon Shinyaku Advance Co., Ltd.

Business lines

Insurance agency business mainly for the Nippon Shinyaku Group, parking lot operation and property leasing for corporate tenants, intermediary service for goods purchase and other service operations, and provision of shared services in administrative and back-office functions of the Nippon Shinyaku Group.

Representative director

Akane Nihei, President

Head Office Address

14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, Japan (on the premises of Nippon Shinyaku)

Established

June 1962
(The Company's name changed in July 2023 from NS Shared Service Co., Ltd. to Nippon Shinyaku Advance Co., Ltd.)

Capital

10 million yen

Percentage of voting rights (%)

100

Employees

92 (as of March 31, 2024)

Website

https://www.ns-advance.co.jp/